MADHAVBAUG — Vaidya Sane Ayurved Laboratories Income Statement
0.000.00%
- IN₹1.75bn
- IN₹1.59bn
- IN₹898.47m
- 73
- 27
- 88
- 71
Annual income statement for Vaidya Sane Ayurved Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 523 | 747 | 992 | 993 | 898 |
Cost of Revenue | |||||
Gross Profit | 346 | 516 | 715 | 736 | 731 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 515 | 699 | 934 | 975 | 814 |
Operating Profit | 7.54 | 48 | 57.4 | 17.9 | 84.5 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.55 | 47.5 | 64.3 | 28.6 | 99 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.92 | 34.7 | 48.3 | 19.9 | 71.5 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 3.92 | 34.7 | 48.3 | 19.8 | 71.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.92 | 34.7 | 48.3 | 19.8 | 71.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.403 | 3.3 | 4.6 | 1.56 | 6.3 |
Dividends per Share |